Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03818919 · ClinicalTrials.gov registry record · Phase 2
Nonopioid Analgesia After Rotator Cuff Repair
A Phase 2 study of Rotator Cuff Tear, sponsored by Henry Ford Health System.
- Completed
- Registry status
- Phase 2
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT03818919: Completed Phase 2 study of Rotator Cuff Tear, sponsored by Henry Ford Health System.
NCT03818919 is a Phase 2 study of Rotator Cuff Tear that has completed, run by Henry Ford Health System. The registered enrollment target is 70 participants, below the 87-participant average among 11 other Rotator Cuff Tear trials with a reported enrollment target (20% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03818919, a Phase 2 study of Rotator Cuff Tear, has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized, single blinded, standard of care controlled clinical trial. This project aims to compare postoperative pain control in patients in two treatment arms of rotator cuff repair: a treatment group given a nonopioid pain control regimen, and a standard of care control group given standard opioid pain control regimen
Primary Outcome
Patients record pain levels using Visual analog scales for 10 days post-operatively. The visual analog scale ranges from 0 (no pain) to 10 (worst pain). Average daily pain was calculated for each patient. Higher values portend worse control.
Conditions Studied
Interventions
- DRUG Acetaminophen
- DRUG Ketorolac
- DRUG Celecoxib
- DRUG Gabapentin
- DRUG Diazepam
Study Locations (1)
Michigan
- Health Ford Health System - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2019-01-22 |
| Est. Completion | 2020-12-31 |
| Phase | Phase 2 |
What the finished NCT03818919 record still lists
NCT03818919 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 87-participant average among 11 other Rotator Cuff Tear trials with a reported enrollment target (20% lower).
The record links to 1 condition, with Rotator Cuff Tear appearing as the primary indexed condition, and to 5 interventions - of which Acetaminophen is the first listed.
NCT03818919 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT03818919 about?
NCT03818919 is a clinical study titled "Nonopioid Analgesia After Rotator Cuff Repair". This is a randomized, single blinded, standard of care controlled clinical trial. This project aims to compare postoperative pain control in patients in two treatment arms of rotator cuff repair: a treatment group given a nonopioid pain control regimen, and a standard of care control group given sta...
What is the current status of trial NCT03818919?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 70 participants. The study started on 2019-01-22. Estimated completion is 2020-12-31.
What conditions does trial NCT03818919 study?
This clinical trial studies the following conditions: Rotator Cuff Tear.
What interventions are being tested in trial NCT03818919?
The interventions under investigation include: Acetaminophen (DRUG), Ketorolac (DRUG), Celecoxib (DRUG), Gabapentin (DRUG), Diazepam (DRUG).
Who is sponsoring clinical trial NCT03818919?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03818919 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rotator Cuff Tear
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03818919's enrollment target sits among peer trials
70 8th of 11 higher than 4 of 11 other Rotator Cuff Tear trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Rotator Cuff Tear trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Stromal Vascular Fraction Cell Therapy to Improve the Repair of Rotator Cuff Tears
ACTIVE NOT RECRUITING · Phase 2
-
FiberLocker® System Augmentation of Rotator Cuff Repairs
RECRUITING · NA
-
Oxandrolone Rotator Cuff Trial
ACTIVE NOT RECRUITING · NA
-
Autologous Adult Adipose-Derived Regenerative Cell Injection Into Chronic Partial-Thickness Rotator Cuff Tears
ACTIVE NOT RECRUITING · NA
-
Rotator Cuff Failure With Continuity
ACTIVE NOT RECRUITING
-
Opioid-Free Shoulder Arthroplasty
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI